2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
16
Carcinoma, Non-Small-Cell Lung
7
Squamous Cell Carcinoma of Head and Neck
5
Breast Neoplasms
5
Head and Neck Neoplasms
4
Lung Neoplasms
3
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Osteosarcoma
2
Oropharyngeal Neoplasms
2
Neuroblastoma
2
Neoplasm Metastasis
2
Mouth Neoplasms
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Adenocarcinoma
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomatitis
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Squamous Cell Cancer of Head and Neck (SCCHN)
1
Skin Neoplasms
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Recurrence
1
Interventions
enzalutamide
7
Prednisone
7
cabazitaxel
6
Radiosurgery
6
Docetaxel
5
Androgen Antagonists
4
Abiraterone Acetate
4
XRP6258
2
Standard of Care
2
talazoparib
1
sipuleucel-T
1
rucaparib
1
pembrolizumab
1
olaparib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
darolutamide
1
apalutamide
1
Zuclomiphene
1
Radiotherapy, Image-Guided
1
Radiotherapy
1
Prednisolone
1
Positron Emission Tomography Computed Tomography
1
Pluvicto
1
Midazolam
1
Lutetium-177
1
Lutetium
1
Lenograstim
1
LY3023414
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostate Cancer Metastatic
×
Radiotherapy, Image-Guided
×
Clear all
NCT04983095
2026-02-17
METRO
Umeå University
Phase NA
Recruiting
118 enrolled